Short interest trends influence cah stock price forecast — current short float is down to 1.9%, indicating reduced bearish sentiment from speculative traders. The the stock of prescription drug distributor has fallen by 2.54% in the past month, leading the Medical sector's loss of 5.64% and undershooting the S&P 500's loss of 0.36%. We estimate that the CEO of CARDINAL HEALTH INC ($CAH), Jason M. Hollar, received a compensation of $18,976,195 in 2025. This is a decrease of -35.18% from an estimated $25,651,209 in 2024. Dividend sustainability analysis backs positive cah stock price forecast, with payout ratios under 40%, leaving room for increases in upcoming fiscal periods.